Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-09T10:47:20.335Z Has data issue: false hasContentIssue false
  • English
  • Français

Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects by using Lifetech™ Konar-MF Occluder device (MFO) – CORRIGENDUM

Published online by Cambridge University Press:  14 December 2022

Ender Odemis  and
Mete Han Kizilkaya
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Corrigendum
Information
Cardiology in the Young , Volume 33 , Issue 10 , October 2023 , pp. 2027
Check for updates
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press

The authors apologise that within the abstract and later in the article the sentence “In the follow-up, at 6th months, only four patients had hemodynamically significant residual defects” was incorrect and should have said “In the follow-up, at 6th months, only four patients had hemodynamically insignificant residual defects”. Reference Odemis and Kizilkaya1

The online version of this article has been updated.

References

Odemis, E, Kizilkaya, M. Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using the Lifetech™ Konar-MF Occluder device (MFO). Cardiol Young 2022: 1–6. doi: 10.1017/S1047951122003547 Google ScholarPubMed